"VSNC is committed to providing comprehensive evaluation and treatment of patients with peripheral arterial disease. We work closely with primary care physicians, podiatrists and wound care specialists to ensure their patients are receiving the best care possible. VSNC offers advanced minimally invasive treatment options for patients in our state-of-the-art facility located in Cary. Unlike other practices in the area, we are an independent physician owned practice providing advanced treatment options only rivaled by a few centers nationally. Our practice is the first of its kind in the state of North Carolina."

During the past decade, Vascular Solutions of North Carolina conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vascular Solutions of North Carolina" #1 collaborator was "Veranex, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Vascular Solutions of North Carolina" are "Peripheral Arterial Disease" (2 trials), "Chronic Limb Threatening Ischemia" (1 trials), "Critical Limb Ischemia" (1 trials), "Ischaemic Ulcer of Lower Leg Due to Atherosclerotic Disease" (1 trials) and "Ischemic Ulcer of Foot" (1 trials). Many other conditions were trialed in "Vascular Solutions of North Carolina" in a lesser frequency.

Most popular intervention types in "Vascular Solutions of North Carolina" are "Device" (3 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "AMG0001" (1 trials), "AngioSafe Peripheral CTO Crossing System" (1 trials), "BioMimics 3D Vascular Stent System" (1 trials), "Drug Eluting Stent - Below the Knee" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vascular Solutions of North Carolina" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Vascular Solutions of North Carolina". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Vascular Solutions of North Carolina, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vascular Solutions of North Carolina, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".